Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy, safety, and tolerability of Crisaborole with and without PF-07038124 and/or NBUVB in Vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Crisaborole (crisaborole)
• PF-07038124

Snippet

Sponsor: University of Colorado, Denver | Conditions: Vitiligo | Phase 2 | Status: COMPLETED